Winder SJ - Search Results

1

Preventing phosphorylation of dystroglycan ameliorates the dystrophic phenotype in mdx mouse.

Miller G, Moore CJ, Terry R, La Riviere T, Mitchell A, Piggott R, Dear TN, Wells DJ, Winder SJ. Miller G, et al. Among authors: winder sj. Hum Mol Genet. 2012 Oct 15;21(20):4508-20. doi: 10.1093/hmg/dds293. Epub 2012 Jul 18. Hum Mol Genet. 2012. PMID: 22810924 Free PMC article.

2

The inside and out of dystroglycan post-translational modification.

Moore CJ, Winder SJ. Moore CJ, et al. Among authors: winder sj. Neuromuscul Disord. 2012 Nov;22(11):959-65. doi: 10.1016/j.nmd.2012.05.016. Epub 2012 Jul 4. Neuromuscul Disord. 2012. PMID: 22770978 Review.

3

Dasatinib as a treatment for Duchenne muscular dystrophy.

Lipscomb L, Piggott RW, Emmerson T, Winder SJ. Lipscomb L, et al. Among authors: winder sj. Hum Mol Genet. 2016 Jan 15;25(2):266-74. doi: 10.1093/hmg/ddv469. Epub 2015 Nov 24. Hum Mol Genet. 2016. PMID: 26604135 Free PMC article.

4

Modulation of cell spreading and cell-substrate adhesion dynamics by dystroglycan.

Thompson O, Moore CJ, Hussain SA, Kleino I, Peckham M, Hohenester E, Ayscough KR, Saksela K, Winder SJ. Thompson O, et al. Among authors: winder sj. J Cell Sci. 2010 Jan 1;123(Pt 1):118-27. doi: 10.1242/jcs.047902. J Cell Sci. 2010. PMID: 20016072 Free PMC article.

5

Dystroglycan versatility in cell adhesion: a tale of multiple motifs.

Moore CJ, Winder SJ. Moore CJ, et al. Among authors: winder sj. Cell Commun Signal. 2010 Feb 17;8:3. doi: 10.1186/1478-811X-8-3. Cell Commun Signal. 2010. PMID: 20163697 Free PMC article.

6

γ-Secretase Dependent Nuclear Targeting of Dystroglycan.

Leocadio D, Mitchell A, Winder SJ. Leocadio D, et al. Among authors: winder sj. J Cell Biochem. 2016 Sep;117(9):2149-57. doi: 10.1002/jcb.25537. Epub 2016 Mar 31. J Cell Biochem. 2016. PMID: 26990187 Free PMC article.

7

Dystroglycan function is a novel determinant of tumor growth and behavior in prostate cancer.

Mitchell A, Mathew G, Jiang T, Hamdy FC, Cross SS, Eaton C, Winder SJ. Mitchell A, et al. Among authors: winder sj. Prostate. 2013 Mar;73(4):398-408. doi: 10.1002/pros.22581. Epub 2012 Sep 19. Prostate. 2013. PMID: 22996647

8

Nuclear targeting of dystroglycan promotes the expression of androgen regulated transcription factors in prostate cancer.

Mathew G, Mitchell A, Down JM, Jacobs LA, Hamdy FC, Eaton C, Rosario DJ, Cross SS, Winder SJ. Mathew G, et al. Among authors: winder sj. Sci Rep. 2013 Sep 30;3:2792. doi: 10.1038/srep02792. Sci Rep. 2013. PMID: 24077328 Free PMC article.

9

Expression of beta-dystroglycan is reduced or absent in many human carcinomas.

Cross SS, Lippitt J, Mitchell A, Hollingsbury F, Balasubramanian SP, Reed MW, Eaton C, Catto JW, Hamdy F, Winder SJ. Cross SS, et al. Among authors: winder sj. Histopathology. 2008 Nov;53(5):561-6. doi: 10.1111/j.1365-2559.2008.03157.x. Histopathology. 2008. PMID: 18983465

10

Ezrin-dependent regulation of the actin cytoskeleton by beta-dystroglycan.

Spence HJ, Chen YJ, Batchelor CL, Higginson JR, Suila H, Carpen O, Winder SJ. Spence HJ, et al. Among authors: winder sj. Hum Mol Genet. 2004 Aug 1;13(15):1657-68. doi: 10.1093/hmg/ddh170. Epub 2004 Jun 2. Hum Mol Genet. 2004. PMID: 15175275

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

109 results

Search Page

Filters